← back to search

Qingqing Liu

Guangzhou University of Chinese Medicine · CN
Area of research
Cardiology and Cardiovascular Medicine · Complementary and alternative medicine
Research interest
Research interests include Medicine, Percutaneous coronary intervention, Conventional PCI, Clinical trial, Adverse effect, and Randomized controlled trial.
h-index
citations
25
works
7
NIH funding
primary concept
email

Recent publications

Impact of exercise-based cardiac rehabilitation on cardiopulmonary function and prognosis in ST elevation myocardial infarction after PCI patients in extremely cold regions
BMC Cardiovascular Disorders 2025cited by 3position: middledoi
Sparstolonin B and Curcumin alleviate atherogenesis by modulating T helper 17-stromal cell interactions associated with interleukin-17 receptor A (IL-17RA) - transforming growth factor-β-activated kinase 1 (TAK1) - nuclear factor-kappa B (NF-κB) signaling
Phytomedicine 2025cited by 1position: middledoi
The Toll-like Receptor-2/4 Antagonist, Sparstolonin B, and Inflammatory Diseases: A Literature Mining and Network Analysis
Cardiovascular Drugs and Therapy 2024cited by 4position: middledoi
Potential role of Chinese medicine nanoparticles to treat coronary artery disease
Heliyon 2023cited by 6position: middledoi
Efficacy and safety of <i>Ginkgo biloba</i> dropping pills in the treatment of coronary heart disease with stable angina pectoris and depression: study protocol for a randomised, placebo-controlled, parallel-group, double-blind and multicentre clinical trial
BMJ Open 2023cited by 3position: middledoi
Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis
Journal of Interventional Cardiology 2023cited by 0position: middledoi
Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy
BMJ Open 2020cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qing Liu · Shanghai University of Traditional Chinese Medicine3 papers (2023–2024)Wenjie Long · Guangzhou University of Chinese Medicine2 papers (2020–2023)Shaoxiang Xian · Guangzhou University of Chinese Medicine2 papers (2020–2023)Zhong-Qi Yang · Guangzhou University of Chinese Medicine2 papers (2020–2023)Rongyuan Yang · Guangzhou University of Chinese Medicine2 papers (2023–2024)Huili Liao · Guangzhou University of Chinese Medicine2 papers (2020–2023)Dawei Wang · SciTech Development (United States)2 papers (2024–2025)Guofu Zhong · Guangzhou University of Chinese Medicine1 papers (2025–2025) · 1 papers (2025–2025)Dawei Wang · Dalian Medical University1 papers (2023–2023)Qi Zhao · Dalian Medical University1 papers (2025–2025)Shui Tian · Nanjing Medical University1 papers (2023–2023)Chuangpeng Li · Guangzhou University of Chinese Medicine1 papers (2025–2025)Tianhui Yuan · Guangzhou University of Chinese Medicine1 papers (2020–2020)Hong Yu · University of Massachusetts Chan Medical School1 papers (2020–2020)Decai Zhu · Guangzhou University of Chinese Medicine1 papers (2023–2023)Siteng Tao · Jilin University1 papers (2025–2025)Tingchun Wu · Guangzhou University of Chinese Medicine1 papers (2023–2023)Yile Ning · Guangzhou University of Chinese Medicine1 papers (2023–2023) · 1 papers (2025–2025)